130 related articles for article (PubMed ID: 36921580)
1. Parkinson's Disease as a Risk Factor for Prostate Adenocarcinoma: A Molecular Point of View.
Liu T; Yang Z; Liu S; Wei J
Gerontology; 2023; 69(8):986-1001. PubMed ID: 36921580
[TBL] [Abstract][Full Text] [Related]
2. Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma.
Zhang D; Zhang M; Zhang Q; Zhao Z; Nie Y
Med Sci Monit; 2020 Jul; 26():e924543. PubMed ID: 32735556
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
Zhou J; Hui X; Mao Y; Fan L
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
[TBL] [Abstract][Full Text] [Related]
4. Analysis of competing endogenous RNA network to identify the key RNAs associated with prostate adenocarcinoma.
Li Y; Yang Z
Pathol Res Pract; 2018 Nov; 214(11):1811-1817. PubMed ID: 30195637
[TBL] [Abstract][Full Text] [Related]
5. Gleason Score-related MT1L as biomarker for prognosis in prostate adenocarcinoma and contribute to tumor progression in vitro.
Liu L; Li Y; Tang S; Yang B; Zhang Q; Xiao R; Hou X; Liu C; Ma L
Int J Biol Markers; 2023 Jun; 38(2):114-123. PubMed ID: 37192745
[TBL] [Abstract][Full Text] [Related]
6. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
Wang W; Li T; Xie Z; Zhao J; Zhang Y; Ruan Y; Han B
J Transl Med; 2024 Jan; 22(1):57. PubMed ID: 38221616
[TBL] [Abstract][Full Text] [Related]
7. Immune infiltration phenotypes of prostate adenocarcinoma and their clinical implications.
Ma Z; Cheng X; Yue T; Shangguan X; Xin Z; Zhang W; Pan J; Wang Q; Xue W
Cancer Med; 2021 Aug; 10(15):5358-5374. PubMed ID: 34128342
[TBL] [Abstract][Full Text] [Related]
8. Database Mining of Genes of Prognostic Value for the Prostate Adenocarcinoma Microenvironment Using the Cancer Gene Atlas.
Zhao X; Hu D; Li J; Zhao G; Tang W; Cheng H
Biomed Res Int; 2020; 2020():5019793. PubMed ID: 32509861
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis on the diagnostic role of circulatory exosome-based miR-92a-3p for osteoblastic metastases in prostate adenocarcinoma.
Ashok G; Das R; Anbarasu A; Ramaiah S
J Mol Recognit; 2023 Aug; 36(8):e3042. PubMed ID: 37258416
[TBL] [Abstract][Full Text] [Related]
10. miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.
Liu X; Chen J; Guan T; Yao H; Zhang W; Guan Z; Wang Y
BMC Syst Biol; 2019 Jan; 13(1):10. PubMed ID: 30665415
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease.
Chen X; Cao W; Zhuang Y; Chen S; Li X
Brain Res Bull; 2021 Dec; 177():53-63. PubMed ID: 34536521
[TBL] [Abstract][Full Text] [Related]
12. A Novel Overall Survival Prediction Signature Based on Comprehensive Research in Prostate Cancer Bone Metastases.
Hu K; Hu X; Duan Y; Li W; Qian J; Chen J
Front Med (Lausanne); 2022; 9():815541. PubMed ID: 35783639
[TBL] [Abstract][Full Text] [Related]
13. Nur77 Serves as a Potential Prognostic Biomarker That Correlates with Immune Infiltration and May Act as a Good Target for Prostate adenocarcinoma.
Hu QY; Liu J; Zhang XK; Yang WT; Tao YT; Chen C; Qian YH; Tang JS; Yao XS; Xu YH; Wang JH
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770929
[TBL] [Abstract][Full Text] [Related]
14. miR-93-5p may be an important oncogene in prostate cancer by bioinformatics analysis.
Yang Y; Jia B; Zhao X; Wang Y; Ye W
J Cell Biochem; 2019 Jun; 120(6):10463-10483. PubMed ID: 30582208
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and Drug Prediction of Parkinson's Disease Based on Immune-Related Genes.
Bao J; Chang W; Zhao Y
J Mol Neurosci; 2022 Sep; 72(9):1809-1819. PubMed ID: 35731466
[TBL] [Abstract][Full Text] [Related]
16. Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson's Disease.
Yin X; Wang M; Wang W; Chen T; Song G; Niu Y; Jiang Z; Gao Z; Wang Z
Parkinsons Dis; 2022; 2022():2877728. PubMed ID: 36105301
[TBL] [Abstract][Full Text] [Related]
17. Screening a novel six critical gene-based system of diagnostic and prognostic biomarkers in prostate adenocarcinoma patients with different clinical variables.
Munir H; Ahmad F; Ullah S; Almutairi SM; Asghar S; Siddique T; Abdel-Maksoud MA; Rasheed RA; Elkhamisy FAA; Aufy M; Yaz H
Am J Transl Res; 2022; 14(6):3658-3682. PubMed ID: 35836886
[TBL] [Abstract][Full Text] [Related]
18. A pan-cancer analysis of the oncogenic role of leucine zipper protein 2 in human cancer.
Feng D; Shi X; Zhu W; Zhang F; Li D; Han P; Wei Q; Yang L
Exp Hematol Oncol; 2022 Sep; 11(1):55. PubMed ID: 36109820
[TBL] [Abstract][Full Text] [Related]
19. A N
Mei W; Jia X; Xin S; Liu X; Jin L; Sun X; Zhang JX; Zhang B; Yang G; Chen P; Ye L
J Oncol; 2022; 2022():8604216. PubMed ID: 35602299
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA profile study identifies an immune-related lncRNA prognostic signature for prostate adenocarcinoma.
Liang L; Xia W; Yao L; Wu Q; Hua L; Cheng G; Wang Z; Zhao R
Int Immunopharmacol; 2021 Dec; 101(Pt A):108267. PubMed ID: 34740081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
